GLN- or ASN-vasopressin compounds

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Oxytocin; vasopressin; related peptides

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530328, 530329, 514807, A61K 3700, C07C10352

Patent

active

047421541

ABSTRACT:
Peptides whose structures resemble those of vasopressin antagonists but have both a carboxamido amino acid unit and a basic amino acid unit in the side chain have good antagonist activity. A species of the invention is [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)-2-(O-ethyl)-D-tyrosine-4-valine-8-glutamine-9-desglycine]-vasopressi n.

REFERENCES:
patent: 4469679 (1984-09-01), Huffman et al.
patent: 4481193 (1984-11-01), Ali et al.
patent: 4481194 (1984-11-01), Ali et al.
M. Manning et al., Nature, 308 652 (1984).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

GLN- or ASN-vasopressin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with GLN- or ASN-vasopressin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GLN- or ASN-vasopressin compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1507282

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.